Ultra Market Research | Global DNA Sequencing Market
Global DNA Sequencing Market
Report ID : 896
Category : Pharmaceuticals,Global
No Of Pages : 105
Published on: December 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global DNA Sequencing Market Introduction Global DNA Sequencing Market is rapidly emerging to revolutionize research in genomics and diagnostic medicine. DNA sequencing can accurately order nucleotides within a DNA molecule, contributing to significant breakthroughs in personalized medicine, genetic study, and drug discovery. The scope of applications of DNA sequencing ranges from cancer studies and infectious disease diagnosis to agricultural and evolutionary biological applications. Recent developments included the development of next-generation sequencing (NGS) technologies that reduced the cost and time associated with sequencing. As of 2023, the market was estimated to be around about USD 10 billion in value, with an anticipated compound annual growth rate of more than 15% from 2024 through 2030. Emerging trends such as portable sequencing devices and integration with artificial intelligence hold much promise for a future full of dynamism within this industry.
Segmentation By Technology • Next-Generation Sequencing (NGS) o Whole Genome Sequencing o Targeted Sequencing o Others • Sanger Sequencing o Capillary Electrophoresis o Dideoxy Sequencing • Third-Generation Sequencing o Single-Molecule Real-Time Sequencing o Nanopore Sequencing • Others
By Application • Clinical Diagnostics o Oncology Cancer Risk Assessment Tumor Profiling o Infectious Diseases Pathogen Identification Drug-Resistance Testing o Others • Drug Discovery and Development o Genomics-Based Drug Target Identification o Biomarker Discovery • Agricultural and Animal Research o Crop Improvement o Livestock Genomics • Forensic Science o DNA Fingerprinting o Paternity Testing
By End-User • Hospitals and Diagnostic Labs o Large Healthcare Institutions o Specialty Clinics • Research Institutes and Academic Centers • Biotechnology and Pharmaceutical Companies • Others
By Geography • North America o United States o Canada • Europe o Germany o France o United Kingdom • Asia-Pacific o China o Japan o India • Rest of the World
Drivers Global DNA sequencing market is fueled by improvements in genomic technologies and the extensive application in the clinic and in research environments. Reducing the costs associated with next-generation sequencing makes it a more acceptable technology to apply in personalized medicine and the early diagnosis of disease. A rising prevalence of genetic diseases and cancers drives demand for genomic tools in healthcare. The initiatives of the government, coupled with funding for genome research, and the integration of AI and big data analytics, also support the growth of the market. Increasing use of sequencing in agriculture and forensic applications underlines its widening application beyond healthcare.
Restraints Despite its potential, the market faces challenges, including the high initial cost of sequencing platforms and the complexity of data interpretation. A lack of skilled professionals in bioinformatics and genomics hinders adoption, particularly in developing regions. Regulatory and ethical concerns about genetic data privacy also pose significant barriers. Moreover, reimbursement policies for sequencing-based diagnostics remain inconsistent, limiting accessibility for patients in certain healthcare systems.
Opportunities Emerging economies have much growth potential since they invest in healthcare infrastructure and genomic research. Innovations in portable sequencing devices and long-read sequencing technologies unlock new applications like real-time pathogen detection. Collaborations between academia and industry players drive forward disease-specific genetic research. Sequencing data integrated with EHRs allows for precision medicine at scale, paving the way for breakthroughs in treatment and prevention.
Trends Latest trends in the Global DNA Sequencing Market are multi-omics approaches that integrate genomics with transcriptomics and proteomics for better understanding of diseases. There is a growing trend towards cloud-based platforms for the storage and analysis of sequencing data, thereby making them more accessible and scalable. Portable and real-time sequencing devices, such as nanopore technologies, are also gaining ground in field-based research and diagnostics. In addition, CRISPR-based genome editing paired with sequencing is revolutionizing therapeutic development and functional genomics studies.
Key Target Audience • Biotechnology and Pharmaceutical Companies • Hospitals and Diagnostic Laboratories • Academic and Research Institutions • Government and Regulatory Bodies • Agricultural Genomics Researchers
Frequently Asked Questions (FAQ's)
As of 2023, the market is valued at approximately USD 10 billion.
North America leads the market, followed by Europe.
Advancements in sequencing technologies, reduced costs, and increased adoption in diagnostics.
High costs, lack of skilled professionals, and regulatory concerns.
Next-generation sequencing (NGS), third-generation sequencing, and AI-integrated platforms.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Technology 3.2.2 By Application 3.2.3 By End-User 3.2.4 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
5. Global DNA Sequencing Market by Application 5.1 Introduction 5.2 Market Size and Growth Rate by Application (2024-2030) 5.2.1 Clinical Diagnostics 5.2.1.1 Oncology 5.2.1.1.1 Cancer Risk Assessment 5.2.1.1.2 Tumor Profiling 5.2.1.2 Infectious Diseases 5.2.1.2.1 Pathogen Identification 5.2.1.2.2 Drug-Resistance Testing 5.2.1.3 Others 5.2.2 Drug Discovery and Development 5.2.2.1 Genomics-Based Drug Target Identification 5.2.2.2 Biomarker Discovery 5.2.3 Agricultural and Animal Research 5.2.3.1 Crop Improvement 5.2.3.2 Livestock Genomics 5.2.4 Forensic Science 5.2.4.1 DNA Fingerprinting 5.2.4.2 Paternity Testing
6. Global DNA Sequencing Market by End-User 6.1 Introduction 6.2 Market Size and Growth Rate by End-User (2024-2030) 6.2.1 Hospitals and Diagnostic Labs 6.2.1.1 Large Healthcare Institutions 6.2.1.2 Specialty Clinics 6.2.2 Research Institutes and Academic Centers 6.2.3 Biotechnology and Pharmaceutical Companies
7. Global DNA Sequencing Market by Geography 7.1 Introduction 7.2 Market Size and Growth Rate by Region (2024-2030) 7.2.1 North America 7.2.1.1 United States 7.2.1.2 Canada 7.2.2 Europe 7.2.2.1 Germany 7.2.2.2 France 7.2.2.3 United Kingdom 7.2.2.4 Rest of Europe 7.2.3 Asia Pacific 7.2.3.1 China 7.2.3.2 Japan 7.2.3.3 India 7.2.3.4 Rest of Asia Pacific 7.2.4 Rest of the World
9. List of Tables and Figures Tables 1. Market Size by Technology (2024-2030) 2. Application-Based Growth Analysis (2024-2030) 3. Regional Market Size and Growth
Figures 1. Global DNA Sequencing Market Overview 2. Technology-Wise Market Share Analysis 3. Regional Dynamics and Market Penetration
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global DNA Sequencing Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global DNA Sequencing Market for the past year and forecasts for the next six years. Global DNA Sequencing Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global DNA Sequencing Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global DNA Sequencing Market from different application industries in different regions
Segmentation By Technology • Next-Generation Sequencing (NGS) o Whole Genome Sequencing o Targeted Sequencing o Others • Sanger Sequencing o Capillary Electrophoresis o Dideoxy Sequencing • Third-Generation Sequencing o Single-Molecule Real-Time Sequencing o Nanopore Sequencing • Others
By Application • Clinical Diagnostics o Oncology Cancer Risk Assessment Tumor Profiling o Infectious Diseases Pathogen Identification Drug-Resistance Testing o Others • Drug Discovery and Development o Genomics-Based Drug Target Identification o Biomarker Discovery • Agricultural and Animal Research o Crop Improvement o Livestock Genomics • Forensic Science o DNA Fingerprinting o Paternity Testing
By End-User • Hospitals and Diagnostic Labs o Large Healthcare Institutions o Specialty Clinics • Research Institutes and Academic Centers • Biotechnology and Pharmaceutical Companies • Others
By Geography • North America o United States o Canada • Europe o Germany o France o United Kingdom • Asia-Pacific o China o Japan o India • Rest of the World
